# FDA Inspection 1062339 - Biomat USA Inc - July 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/36434056-d0f8-49ce-b204-a34403a76cd9
Source feed: FDA_Inspections

> FDA Inspection 1062339 for Biomat USA Inc on July 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062339
- Company Name: Biomat USA Inc
- Inspection Date: 2018-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 950741 - 2015-11-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c46a1151-8f7a-46e0-9534-5287f03f5ef6)
- [FDA Inspection 887239 - 2014-07-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/30289b9e-ba59-41aa-95c0-6a49e37420a7)
- [FDA Inspection 855254 - 2013-11-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/28c517e0-0014-4298-a050-150dfad00e3e)
- [FDA Inspection 794963 - 2012-08-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e055c29f-098c-4cae-b3e7-794aef11ec12)
- [FDA Inspection 661175 - 2010-05-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1d5c08b1-1168-44b6-8abe-76086c166918)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8b88170d-2292-4ec4-8c4c-9d4800cae677

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d